Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
US7524965B2 · kind B2 · utility
33Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2007 |
| Grant date | Apr 28, 2009 |
| Priority date | — |
| Expiry date | May 6, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of formula I:wherein R1 and R2 are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions and combinations comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compound to, for example, treat pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.